Adjuvant doxorubicin, cyclophosphamide, and paclitaxel in treating patients with breast cancer

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT00070564?term=S0221&rank=1

2. Intervention

   Doxorubicin

3. Intervention

   Paclitaxel

4. Intervention

   Cyclophosphamide

5. Intervention

   Antineoplastic combined chemotherapy

6. Resource Description

   This randomized phase III trial is comparing 2 different regimens of combination chemotherapy to see how well they work in treating patients who have undergone surgery for stage I, stage II, or stage III breast cancer.

7. Additional Name

   Phase III trial of continuous schedule AC + G vs. q 2 week schedule AC, followed by paclitaxel given either every 2 weeks or weekly for 12 weeks as post-operative adjuvant therapy in node-positive or high-risk node-negative breast cancer

8. Contact

   Berenberg, Jeffrey

9. PI

   Berenberg, Jeffrey

10. Topic

    breast cancer

11. Funded by

    SWOG

12. Phase

    Phase 3 clinical trial

13. Performed by

    Clinical Protocol & Data Management Shared Resource